article thumbnail

China’s Rise in U.S. Design Patent System

Patently-O

WIPO administers the WIPO-administered Hague System for the International Registration of Industrial Designs. In 2015, the US linked its design patent system with Hague — this gives U.S. designers easier access to global design rights; and non-U.S. design patent system. applicants easier access to the U.S.

article thumbnail

Biosimilars 2021 Year in Review

JD Supra Law

2021 saw several important milestones in the biosimilars space, including the much anticipated first interchangeable designations by FDA and the approval of the first ophthalmology biosimilar. The biosimilar market also exhibited continued growth, with multiple biosimilar developers reporting strong sales of biosimilars through 2021.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Light Administrative Injunctions for Designs in China: Status-check on the 2021 Shenzhen AMR Reform

IP Tech Blog

. In June 2021 the Shenzhen Administration for Market Regulation (Shenzhen AMR) issued the first ever provisions on administrative injunctions against the infringement of a design patents, including online infringements. Other cities and provinces started similar provisions in the summer of 2021. on April 19, 2021.

Designs 62
article thumbnail

Another “brick” in Lego’s modular systems design protection

The IPKat

By decision of 24 January 2024 ( T-537/22 ), the General Court of the European Union (GC) confirmed the validity of the Registered Community Design (RCD) by Lego A/S (Lego) “Building blocks from a toy building set” by stating that an RCD is invalid only if all its features are excluded from protection. On 2 February 2010 Lego obtained RCD No.

Designs 70
article thumbnail

Year in Review: Top-Five U.S. Biosimilar Market Developments of 2021

LexBlog IP

biosimilar market developments of 2021. This interchangeable designation was based on the FDA’s “rigorous approval standards,” including evidence that showed the reference product and biosimilar are highly similar and have no clinically meaningful differences in terms of safety, purity and potency.

article thumbnail

Light Administrative Injunctions for Designs in China: Status-check on the 2021 Shenzhen AMR Reform

LexBlog IP

In June 2021 the Shenzhen Administration for Market Regulation (Shenzhen AMR) issued the first ever provisions on administrative injunctions against the infringement of a design patents, including online infringements. Other cities and provinces started similar provisions in the summer of 2021.

Designs 52
article thumbnail

M&S "gin-joys" registered design victory against Aldi in E&W Court of Appeal judgment regarding flavoured liqueur lookalikes

The IPKat

In a decision delivered this week, the Court of Appeal of England and Wales (the Court) has upheld the design infringement claim brought by Marks and Spencer (M&S) against Aldi in respect of their gin-based flavoured liqueur range, in what may be a catalyst for a shift from trade mark law to design law for product "lookalike" claims.

Designs 62